Skip to main content

Reporter Dec 10 2021

Immune landscape in adrenal cancer

Dec. 14, 2021—The profile of immune-related gene expression and tumor-infiltrating immune cells in adrenocortical cancer suggests targets for new treatment strategies.

Read more


Oral microbes and gastric cancer

Dec. 13, 2021—Studies in three large population cohorts that include Asian, African American and European American people support a role for the oral microbiota — the collection of microbial species in the mouth — in gastric cancer development.

Read more


“Supermeres” may carry clues to cancer, Alzheimer’s disease and COVID-19

Dec. 10, 2021—Vanderbilt researchers have discovered a nanoparticle released from cells, called a “supermere,” which contains enzymes, proteins and RNA associated with multiple cancers, cardiovascular disease, Alzheimer’s disease and even COVID-19.

Read more


Former chair of Biochemistry Michael Waterman has died

Dec. 9, 2021—Michael Waterman, PhD, former chair of the Department of Biochemistry for 18 years, died Nov. 7

Read more


Antibodies discovered at Vanderbilt for prevention of COVID-19 granted FDA emergency use authorization

Dec. 9, 2021—The U.S. Food and Drug Administration granted emergency use authorization (EUA) to the global biopharmaceutical company AstraZeneca for a long-acting antibody combination which  protects against COVID-19, discovered last year at Vanderbilt University Medical Center.

Read more


Cell signaling targets in leukemia

Dec. 9, 2021—Vanderbilt researchers identified a critical role for IL-1beta signaling in leukemia cells with a certain mutation, suggesting this pathway may be a good target for novel treatments.

Read more


Prostate cancer treatment regret

Dec. 9, 2021—Vanderbilt researchers suggest that to reduce treatment-related regret for men with localized prostate cancer, treatment preparation should focus on shared decision-making and aligning patient expectations with treatment toxicity.

Read more


VUMC nurses land VUSN Preceptor of the Year Awards

Dec. 9, 2021—Three nurses at Vanderbilt University Medical Center have been selected in the inaugural group of Preceptor of the Year Awards by Vanderbilt University School of Nursing.

Read more


Virtual memorial service now available for viewing

Dec. 9, 2021—“VUMC Remembers,” a special virtual memorial service to remember patients who have died as well as their families and caregivers, is now posted at vumcremembers.com.

Read more


Vision foundation’s longtime support key to Penn’s research efforts

Dec. 9, 2021—  by Nancy Humphrey John S. Penn, PhD, has been named the inaugural holder of the Knights Templar Eye Foundation (KTEF) Directorship in Pediatric Vision Research at the Vanderbilt Eye Institute in honor of his contributions to the foundation and the field of vision research. Penn’s connection with the KTEF, which is committed to supporting...

Read more


Pioneer of substance abuse prevention and treatment Anderson Spickard Jr., MD, mourned

Dec. 8, 2021—Vanderbilt's Anderson Spickard Jr., MD, professor of Medicine Emeritus and director Emeritus, Center for Professional Health, died Dec. 8 He was 90.

Read more


International study supports dupilumab for treatment of moderate-to-severe asthma in children

Dec. 8, 2021—In a late-stage clinical trial, the biologic agent dupilumab reduced the rate of severe asthma attacks and improved lung function and asthma control for children ages 6 to 11 with moderate-to-severe asthma, offering a new option to these patients.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more